Navigate
Home
Join
Renew
About Us
Mission & Vision
Board of Directors
Diversity & Inclusion
Staff
Press Room
Disclosures and Conflicts of Interest
Find an MFM Subspecialist
Advertise with SMFM
Annual Reports
Clinical Guidance
Clinical Publications and Guidelines
Hypertension in Pregnancy
Infectious Disease Resources
SMFM Checklists and Patient Safety Bundles
Publish Your Research
Reproductive Health
Advocacy
Advocacy Hub
Support Abortion Access
Coalition to Advance Maternal Therapeutics
Maternal Mortality Scorecard
For Patients & Families
Online Education
Meetings & Events
Coding for Maternal-Fetal Medicine Course
Dan O'Keeffe Leadership Academy
First-Year Fellows Workshop and Retreat
Maternal Medicine Course
Practice Management Course
Prenatal Genetics Course
SMFM Global Congress
Pregnancy Meeting™
Exhibit & Sponsor
Practice Management
Online Coding Resources
Consulting Services
Telehealth
Webinars
Contemporary Guide to Practice Management
Career Center
Membership
Get Involved
Committees
Join/Renew
MFM Fellowship
Member Spotlight
Online Communities
Online Store
Resident Recognition Awards
Special Delivery e-Newsletter
Reproductive Health Updates
Newsroom
Career Opportunities
Contact
Foundation for SMFM
Career Center
Contact Us
Facebook
Twitter
C
Login
|
Join
Search
Search
Home
»
Publications & Guidelines
» ACOG-SMFM Practice Advisory: Use of Antenatal Corticosteroids at 22 Weeks of ...
ACOG-SMFM Practice Advisory: Use of Antenatal Corticosteroids at 22 Weeks of Gestation
Tags:
corticosteriod
,
anticoagulation
,
pregnancy
Categories:
Joint Publication
back
